🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05466396
Recruiting Observational

Lung Health of Early COPD: A Multi-center Cohort Study

NCT05466396 · tracked via the Priya Life Science China tracker
Sponsor
Ting YANG
Phase
Observational
Started
2022-08-01
Last updated
2025-02-17

Condition(s) studied

COPD

Investigational drug(s) / intervention(s)

smoking

smoking: Smoking history and spirometry are used to define groups

Study summary

This is a multi-center, prospective, cohort study in early COPD patients. This study aims to elucidate the lung function decline and its association with smoking and other risk factors. Other biomarkers and image markers from chest CT scan are also analyzed to investigate the lung function in early COPD patients.

Eligibility

Sex
ALL
Min age
35 Years
Max age
75 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Gender: male or female 2. Age: 35-75 years old 3. post-bronchodilator spirometry: FEV1/FVC \< 0.8 and FEV1%pred ≥80% Exclusion Criteria: 1. Other diseases may affect lung function, like lung cancer, bronchiectasis, interstitial lung disease or chest surgery. 2. BMI \> 35 kg/m2 3. Dementia or other severe neurological disease 4. Pregnancy 5. Conditions that contraindicated lung function test

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
China-Japan Friendship Hospital Beijing Beijing Municipality Recruiting
Affiliated Hospital of Zunyi Medical University Zunyi Guizhou Recruiting

More Ting YANG trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05466396 on ClinicalTrials.gov ↗ ← All trials in China